المؤلفون: Nuredin Chura Waritu, Suresh Kumar P. Nair, Rashed Edris Usure, Mohammed Jemal

المصدر: Frontiers in Medicine, Vol 11 (2024)

مصطلحات موضوعية: hyperuricemia, high-sensitivity C-reactive protein, dolutegravir, ritonavir-boosted atazanavir, HIV, Medicine (General), R5-920

وصف الملف: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fmed.2024.1370725/full; https://doaj.org/toc/2296-858X

URL الوصول: https://doaj.org/article/ea3bbdd905824e29860a42f9cf61e53c

المؤلفون: Muche Belete A, Seifu D, Menon M, Amogne W, Shewa A, Adela Tefera A

المصدر: HIV/AIDS: Research and Palliative Care, Vol Volume 13, Pp 217-227 (2021)

مصطلحات موضوعية: dyslipidemia, antiretroviral therapy, efavirenz, ritonavir-boosted atazanavir, Immunologic diseases. Allergy, RC581-607

وصف الملف: electronic resource

Relation: https://www.dovepress.com/serum-lipid-profiles-of-patients-taking-efavirenz-based-antiretroviral-peer-reviewed-article-HIV; https://doaj.org/toc/1179-1373

URL الوصول: https://doaj.org/article/9f4e7399e88841d18af284d46046ebd0

المؤلفون: d'Arminio Monforte, A, Lorenzini, P, Cozzi-Lepri, A, Mussini, C, Castagna, A, Baldelli, F, Puoti, M, Vichi, F, Maddaloni, A, Lo Caputo, S, Gianotti, N, Antinori, A, on behalf of the Icona Foundation Study Group, .

المصدر: HIV Clinical Trials , 19 (2) pp. 52-60. (2018)

مصطلحات موضوعية: Cohort study, antiretroviral regimens, boosted-atazanavir, boosted-darunavir, raltegravir, therapy discontinuation

وصف الملف: text

Relation: https://discovery.ucl.ac.uk/id/eprint/10045414/1/Cozzi-Lepri_Paper_HCT_darminio.pdf; https://discovery.ucl.ac.uk/id/eprint/10045414/

الاتاحة: https://discovery.ucl.ac.uk/id/eprint/10045414/1/Cozzi-Lepri_Paper_HCT_darminio.pdf
https://discovery.ucl.ac.uk/id/eprint/10045414/

المؤلفون: Abebe Muche Belete, Daniel Seifu, Aster Shewa, Menakath Menon, Alemu Adela Tefera, Wondwossen Amogne

المصدر: HIV/AIDS (Auckland, N.Z.)

مصطلحات موضوعية: medicine.medical_specialty, Efavirenz, Epidemiology, antiretroviral therapy, Dermatology, 030312 virology, HIV/AIDS - Research and Palliative Care, Gastroenterology, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Virology, Internal medicine, medicine, ritonavir-boosted atazanavir, 030212 general & internal medicine, Original Research, 0303 health sciences, medicine.diagnostic_test, business.industry, Health Policy, dyslipidemia, Lamivudine, efavirenz, medicine.disease, Atazanavir, Regimen, Infectious Diseases, chemistry, lipids (amino acids, peptides, and proteins), Ritonavir, Lipid profile, business, Body mass index, Dyslipidemia, medicine.drug

وصف الملف: text/html

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::967b17a5a89db5c40583e7ef06fda6b6
https://doi.org/10.2147/hiv.s296170

المؤلفون: Llibre, Josep M., Cozzi-Lepri, Alessandro, Pedersen, Court, Ristola, Matti, Losso, Marcelo, Mocroft, Amanda, Mitsura, Viktar, Falconer, Karolin, Maltez, Fernando, Beniowski, Marek, Vullo, Vincenzo, Hassoun, Gamal, Kuzovatova, Elena, Szlavik, Janos, Kuznetsova, Anastasiia, Stellbrink, Hans-Juergen, Duvivier, Claudine, Edwards, Simon, Laut, Kamilla, Paredes, Roger

المساهمون: Clinicum, Department of Medicine, Infektiosairauksien yksikkö

مصطلحات موضوعية: atazanavir, HIV-1, protease inhibitors: abacavir, simplification antiretroviral therapy, HIV-INFECTED PATIENTS, ACTIVE ANTIRETROVIRAL THERAPY, BOOSTED ATAZANAVIR, HEPATITIS-C, RITONAVIR, EFFICACY, SAFETY, REGIMENS, PROTEASE, ADULTS, General medicine, internal medicine and other clinical medicine

وصف الملف: application/pdf

Relation: Primary funding for EuroSIDA is provided by the European Union's Seventh Framework Programme for research, technological development, and demonstration under EuroCoord grant agreement no. 260694. Current support also includes unrestricted grants by Bristol-Myers Squibb, Janssen R&D, Merck and Co. Inc, Pfizer Inc, Glaxo-Smith Kline LLC. The participation of centers from Switzerland was supported by The Swiss National Science Foundation (grant 108787). Study supported by grant [grant no. DNRF126] from the Danish National Research Foundation. The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the article; or decision to submit the article for publication.; Llibre , J M , Cozzi-Lepri , A , Pedersen , C , Ristola , M , Losso , M , Mocroft , A , Mitsura , V , Falconer , K , Maltez , F , Beniowski , M , Vullo , V , Hassoun , G , Kuzovatova , E , Szlavik , J , Kuznetsova , A , Stellbrink , H-J , Duvivier , C , Edwards , S , Laut , K & Paredes , R 2016 , ' Long-term effectiveness of unboosted atazanavir plus abacavir/lamivudine in subjects with virological suppression : A prospective cohort study ' , Medicine (Baltimore) , vol. 95 , no. 40 , 5020 . https://doi.org/10.1097/MD.0000000000005020; ORCID: /0000-0001-5115-2811/work/29386483; http://hdl.handle.net/10138/169330; 252a0a9b-13b3-4d0c-9fe3-092b839186b1; 84995686661; 000386350900044

الاتاحة: http://hdl.handle.net/10138/169330

المؤلفون: Teófilo, Eugénio, Rocha-Pereira, Nuno, Kuhlmann, Birger, Antela, Antonio, Knechten, Heribert, Santos, Jesús, Jiménez-Expósito, Maria Jesús, REMAIN study group

مصطلحات موضوعية: HIV-1, antiretroviral therapy, estimated glomerular filtration rate, hyperbilirubinemia, observational study, persistence, resistance, ritonavir-boosted atazanavir, Adolescent, Adult, Atazanavir Sulfate, Cohort Studies, Drug Administration Schedule, Europe, Female, HIV Infections, Humans, Kidney Diseases, Male, Middle Aged, Ritonavir, Treatment Outcome, Young Adult

وصف الملف: application/pdf

Relation: http://hdl.handle.net/10668/9851; PMC4975100; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4975100/pdf

الاتاحة: http://hdl.handle.net/10668/9851
https://doi.org/10.1080/15284336.2015.1112494
https://www.tandfonline.com/doi/pdf/10.1080/15284336.2015.1112494?needAccess=true
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4975100/pdf

المؤلفون: Amir Ishaq Khan, Eric M. Ghiraldi, Folawiyo Laditi, Ankur Choksi, Dinesh Singh, Tashzna Jones

المصدر: Urology Case Reports
Urology Case Reports, Vol 39, Iss, Pp 101763-(2021)

مصطلحات موضوعية: medicine.medical_specialty, Flank pain, Urology, Urinary stone, Urinary system, PI, protease inhibitor, Urolithiasis, immune system diseases, Surgical removal, ATV/r, ritonavir-boosted atazanavir, medicine, Urinary calculus, Kidney stone, Ritonavir, business.industry, virus diseases, medicine.disease, UVJ, uterovesicular junction, Diseases of the genitourinary system. Urology, CT, computed tomography, Atazanavir, HIV/AIDS, Kidney stones, RC870-923, business, Endourology, CT, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a3fb8a08d8dee2b558c1e5d294f6153
https://doi.org/10.1016/j.eucr.2021.101763

المؤلفون: Hideki Uchiumi, Hiroaki Mitsuya, Hirokazu Komatsu, Hiroyuki Gatanaga, Kiyonori Takada, Masahide Horiba, Masahiro Yamamoto, Masaki Yoshida, Masao Tateyama, Michiyo Ishisaka, Mikio Ueda, Misao Takano, Natsuo Tachikawa, Satoru Kaneda, Satoshi Higasa, Shinichi Oka, Shuzo Matsushita, Takeshi Nishijima, Teruhisa Fujii, Tomohiko Koibuchi, Tomoyuki Endo, Toshio Naito, Yoshimi Kikuchi, Yoshinari Tanabe, Yoshiyuki Yokomaku, on behalf of the Epzicom-Truvada study team

المصدر: Internal Medicine. 2013, 52(7):735

المؤلفون: d'Arminio Monforte, Antonella, Lorenzini, Patrizia, Cozzi-Lepri, Alessandro, Mussini, Cristina, Castagna, Antonella, Baldelli, Franco, Puoti, Massimo, Vichi, Francesca, Maddaloni, Adelaide, Lo Caputo, Sergio, Gianotti, Nicola, Antinori, Andrea

المساهمون: d'Arminio Monforte, Antonella, Lorenzini, Patrizia, Cozzi-Lepri, Alessandro, Mussini, Cristina, Castagna, Antonella, Baldelli, Franco, Puoti, Massimo, Vichi, Francesca, Maddaloni, Adelaide, Lo Caputo, Sergio, Gianotti, Nicola, Antinori, Andrea

مصطلحات موضوعية: Cohort study, antiretroviral regimen, boosted-atazanavir, boosted-darunavir, raltegravir, therapy discontinuation

Relation: info:eu-repo/semantics/altIdentifier/wos/WOS:000432544000003; volume:19; issue:2; firstpage:52; lastpage:60; numberofpages:9; journal:HIV CLINICAL TRIALS; http://hdl.handle.net/20.500.11768/78753

الاتاحة: https://hdl.handle.net/20.500.11768/78753
https://doi.org/10.1080/15284336.2018.1440691

المؤلفون: d'Arminio Monforte, A., Lorenzini, P., Cozzi-Lepri, A., Mussini, C., Castagna, A., Baldelli, F., Puoti, M., Vichi, F., Maddaloni, A., Lo Caputo, S., Gianotti, N., Antinori, A., Segala, D., Sighinolfi, L.

المساهمون: d'Arminio Monforte, A, Lorenzini, P, Cozzi-Lepri, A, Mussini, C, Castagna, A, Baldelli, F, Puoti, M, Vichi, F, Maddaloni, A, Lo Caputo, S, Gianotti, N, Antinori, A, d'Arminio Monforte, Antonella, Lorenzini, Patrizia, Cozzi-Lepri, Alessandro, Mussini, Cristina, Castagna, Antonella, Baldelli, Franco, Puoti, Massimo, Vichi, Francesca, Maddaloni, Adelaide, Lo Caputo, Sergio, Gianotti, Nicola, Antinori, Andrea

مصطلحات موضوعية: 0301 basic medicine, Adult, Male, medicine.medical_specialty, Antiretroviral Therapy, HIV Infections, antiretroviral regimens, boosted-atazanavir, boosted-darunavir, Cohort study, raltegravir, therapy discontinuation, Antiretroviral Therapy, Highly Active, Female, HIV Integrase Inhibitors, HIV Protease Inhibitors, Humans, Middle Aged, Reverse Transcriptase Inhibitors, Treatment Failure, Viral Load, Withholding Treatment, antiretroviral regimen, Gastroenterology, NO, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, Highly Active, Pharmacology (medical), 030212 general & internal medicine, Darunavir, Infectious Diseases, Proportional hazards model, business.industry, Raltegravir, 030112 virology, Discontinuation, Atazanavir, Tolerability, Cohort, Ritonavir, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::614bddbf9d5642eda32f47455acfabd3
http://hdl.handle.net/11391/1437753

المؤلفون: Llibre, J. M., Cozzi-Lepri, A., Pedersen, C., Ristola, M., Losso, M., Mocroft, A., Mitsura, V., Falconer, K., Maltez, F., Beniowski, M., Vullo, V., Hassoun, G., Kuzovatova, E., Szlavik, J., Kuznetsova, A., Stellbrink, H. -J., Duvivier, C., Edwards, S., Laut, K., Paredes, R., Kundro, M., Vetter, N., Zangerle, R., Karpov, I., Vassilenko, A., Mitsura, V. M., Paduto, D., Clumeck, N., De Wit, S., Delforge, M., Florence, E., Vandekerckhove, L., Hadziosmanovic, V., Kostov, K., Begovac, J., Machala, L., Jilich, D., Sedlacek, D., Kronborg, G., Benfield, T., Gerstoft, J., Katzenstein, T., Moller, N. F., Ostergaard, L., Dragsted, U. B., Nielsen, L. N., Zilmer, K., Smidt, J., Aho, I., Viard, J. -P., Girard, P. -M., Cotte, L., Pradier, C., Fontas, E., Dabis, F., Neau, D., Rockstroh, J., Schmidt, R., Degen, O., Stellbrink, H. J., Stefan, C., Bogner, J., Fatkenheuer, G., Chkhartishvili, N., Kosmidis, J., Gargalianos, P., Xylomenos, G., Lourida, P., Sambatakou, H., Gottfredsson, M., Mulcahy, F., Yust, I., Turner, D., Burke, M., Shahar, E., Elinav, H., Haouzi, M., Elbirt, D., Sthoeger, Z. M., D'Arminio Monforte, A., Esposito, R., Mazeu, I., Mussini, C., Mazzotta, F., Gabbuti, A., Lichtner, M., Zaccarelli, M., Antinori, A., Acinapura, R., Plazzi, M., Lazzarin, A., Castagna, A., Gianotti, N., Galli, M., Ridolfo, A., Rozentale, B., Uzdaviniene, V., Matulionyte, R., Staub, T., Hemmer, R., Reiss, P., Ormaasen, V., Maeland, A., Bruun, J., Knysz, B., Gasiorowski, J., Inglot, M., Horban, A., Bakowska, E., Flisiak, R., Grzeszczuk, A., Parczewski, M., Pynka, M., Maciejewska, K., Mularska, E., Smiatacz, T., Gensing, M., Jablonowska, E., Malolepsza, E., Wojcik, K., Mozer-Lisewska, I., Doroana, M., Caldeira, L., Mansinho, K., Radoi, R., Oprea, C., Rakhmanova, A., Trofimora, T., Khromova, I., Jevtovic, D., Shunnar, A., Stanekova, D., Tomazic, J., Gatell, J. M., Miro, J. M., Moreno, S., Rodriguez, J. M., Clotet, B., Jou, A., Tural, C., Puig, J., Bravo, I., Domingo, P., Gutierrez, M., Mateo, G., Sambeat, M. A., Laporte, J. M., Thalme, A., Sonnerborg, A., Blaxhult, A., Flamholc, L., Ledergerber, B., Weber, R., Cavassini, M., Calmy, A., Furrer, H., Battegay, M., Schmid, P., Kravchenko, E., Frolov, V., Kutsyna, G., Baskakov, I., Kyselyova, G., Sluzhynska, M., Gazzard, B., Johnson, A. M., Simons, E., Phillips, A., Johnson, M. A., Orkin, C., Weber, J., Scullard, G., Clarke, A., Leen, C., Lundgren, J., Grarup, J., Thiebaut, R., Burger, D., Peters, L., Matthews, C., Fischer, A. H., Bojesen, A., Raben, D., Kristensen, D., Larsen, J. F., Podlekareva, D., Shepherd, L., Schultze, A.

المساهمون: Clinicum, Department of Medicine, Infektiosairauksien yksikkö, Llibre, Josep M, Cozzi-lepri, Alessandro, Pedersen, Court, Ristola, Matti, Losso, Marcelo, Mocroft, Amanda, Mitsura, Viktar, Falconer, Karolin, Maltez, Fernando, Beniowski, Marek, Vullo, Vincenzo, Hassoun, Gamal, Kuzovatova, Elena, Szlavik, Jano, Kuznetsova, Anastasiia, Stellbrink, Hans-jurgen, Duvivier, Claudine, Edwards, Simon, Laut, Kamilla, Paredes, Roger, on behalf of EuroSIDA, Study, Castagna, Antonella

المصدر: Llibre, J M, Cozzi-Lepri, A, Pedersen, C, Ristola, M, Losso, M, Mocroft, A, Mitsura, V, Falconer, K, Maltez, F, Beniowski, M, Vullo, V, Hassoun, G, Kuzovatova, E, Szlavik, J, Kuznetsova, A, Stellbrink, H-J, Duvivier, C, Edwards, S, Laut, K, Paredes, R & EuroSIDA Study 2016, ' Long-term effectiveness of unboosted atazanavir plus abacavir/lamivudine in subjects with virological suppression : A prospective cohort study ', Medicine, vol. 95, no. 40, e5020 . https://doi.org/10.1097/MD.0000000000005020
Medicine
EuroSIDA Study 2016, ' Long-term effectiveness of unboosted atazanavir plus abacavir/lamivudine in subjects with virological suppression : A prospective cohort study ', Medicine (United States), vol. 95, no. 40, e5020 . https://doi.org/10.1097/MD.0000000000005020

مصطلحات موضوعية: Male, 0301 basic medicine, Sex Factor, HEPATITIS-C, Gastroenterology, 0302 clinical medicine, Abacavir, Drug Combination, Age Factor, Prospective Studies, 030212 general & internal medicine, Prospective cohort study, atazanavir, ACTIVE ANTIRETROVIRAL THERAPY, Medicine (all), Hazard ratio, Age Factors, Lamivudine, General Medicine, Middle Aged, Viral Load, Dideoxynucleoside, 3. Good health, Drug Combinations, SAFETY, Drug Therapy, Combination, Female, Human, Research Article, medicine.drug, Adult, medicine.medical_specialty, abacavir, Simplification antiretroviral therapy [Atazanavir, HIV-1, Protease inhibitors], PROTEASE, Anti-HIV Agents, Atazanavir Sulfate, 030106 microbiology, Observational Study, RITONAVIR, HIV-INFECTED PATIENTS, REGIMENS, Atazanavir, 03 medical and health sciences, Sex Factors, Internal medicine, medicine, Humans, Simplification antiretroviral therapy, HIV Protease Inhibitor, protease inhibitors: abacavir, Ritonavir, abacavir [Protease inhibitors], business.industry, Anti-HIV Agent, HIV Protease Inhibitors, Abacavir/Lamivudine, ADULTS, EFFICACY, BOOSTED ATAZANAVIR, Dideoxynucleosides, Surgery, Discontinuation, simplification antiretroviral therapy, Prospective Studie, 3121 General medicine, internal medicine and other clinical medicine, business

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc54a998b35cd1a8c46620f8519042b2
http://hdl.handle.net/10138/169330

المؤلفون: (Lin, KY), (Liao, SH), (Liu, WC), (Cheng, A), (Lin, SW), (Chang, SY), (Tsai, MS), (Kuo, CH), (Wu, MR), (Wang, HP)*, 洪健清(Chien-Ching Hung)*, (Chang, SC)

المساهمون: 中國附醫醫學研究部遺傳中心

مصطلحات موضوعية: SINGLE-NUCLEOTIDE POLYMORPHISMS, RITONAVIR-BOOSTED ATAZANAVIR, C VIRUS-INFECTION, STONE DISEASE, UDP-GLUCURONOSYLTRANSFERASE, GALLSTONE DISEASE, POPULATION, EPIDEMIOLOGY, PREVALENCE, MANAGEMENT

Relation: PLoS One 10(9):e1037660; http://ir.cmu.edu.tw/ir/handle/310903500/55782; http://ir.cmu.edu.tw/ir/bitstream/310903500/55782/-1/BB-1J04_20151013094422.docx

الاتاحة: http://ir.cmu.edu.tw/ir/handle/310903500/55782
http://ir.cmu.edu.tw/ir/bitstream/310903500/55782/-1/BB-1J04_20151013094422.docx

المؤلفون: Yombi, Jean C., Pozniak, Anton, Boffito, Marta, Jones, Rachael, Khoo, Saye, Levy, Jeremy, Post, Frank A.

المصدر: Yombi , J C , Pozniak , A , Boffito , M , Jones , R , Khoo , S , Levy , J & Post , F A 2014 , ' Antiretrovirals and the kidney in current clinical practice : renal pharmacokinetics, alterations of renal function and renal toxicity ' , Aids , vol. 28 , no. 5 , pp. 621-632 . https://doi.org/10.1097/QAD.0000000000000103

مصطلحات موضوعية: pharmacokinetics, therapy, HIV, estimated glomerular filtration rate, kidney, transporters, HIV-INFECTED PATIENTS, RITONAVIR-BOOSTED ATAZANAVIR, GLOMERULAR-FILTRATION-RATE, TENOFOVIR DISOPROXIL FUMARATE, ACUTE INTERSTITIAL NEPHRITIS, CO-FORMULATED ELVITEGRAVIR, NON-INFERIORITY TRIAL, DOUBLE-BLIND, INITIAL TREATMENT, DRUG-INTERACTIONS

الاتاحة: https://kclpure.kcl.ac.uk/portal/en/publications/2ce14c9a-4b19-44ef-bd21-a655e8c071f9
https://doi.org/10.1097/QAD.0000000000000103

المؤلفون: Ryom, Lene, Mocroft, Amanda, Kirk, Ole, Worm, Signe W, Kamara, David A, Reiss, Peter, Ross, Michael, Fux, Christoph A, Morlat, Philippe, Moranne, Olivier, Smith, Colette, Lundgren, Jens D, D:A:D Study group, the, Vandekerckhove, Linos

المصدر: JOURNAL OF INFECTIOUS DISEASES ; ISSN: 0022-1899

مصطلحات موضوعية: Medicine and Health Sciences, eGFR, HIV, ART, tenofovir, atazanavir, lopinavir, chronic kidney disease, nephrotoxicity, CHRONIC KIDNEY-DISEASE, TENOFOVIR DISOPROXIL FUMARATE, NEPHROGENIC DIABETES-INSIPIDUS, GLOMERULAR-FILTRATION-RATE, ACQUIRED-IMMUNODEFICIENCY-SYNDROME, RITONAVIR-BOOSTED ATAZANAVIR, ACUTE INTERSTITIAL NEPHRITIS, INFECTED PATIENTS, PROTEASE INHIBITOR, FANCONI-SYNDROME

وصف الملف: application/pdf

Relation: https://biblio.ugent.be/publication/4350968; http://hdl.handle.net/1854/LU-4350968; http://dx.doi.org/10.1093/infdis/jit043; https://biblio.ugent.be/publication/4350968/file/4351021

الاتاحة: https://biblio.ugent.be/publication/4350968
http://hdl.handle.net/1854/LU-4350968
https://doi.org/10.1093/infdis/jit043
https://biblio.ugent.be/publication/4350968/file/4351021

المؤلفون: Jansen, Klaus, Sönnerborg, Anders, Brockmeyer, Norbert, Thalme, Anders, Svedhem, Veronica, Dupke, Stephan, Eychenne, Jean-Luc, Nakonz, Tina, Jimenez-Exposito, Maria Jesus, Pugliese, Pascal

المصدر: Aids research and human retroviruses

مصطلحات موضوعية: ddc:610, 80 and over, Adolescent, Adult, Aged, Anti-HIV Agents, Antiretroviral Therapy, BOOSTED ATAZANAVIR, CLINICAL-TRIALS, Cohort Studies, Combination, Data Collection, Databases, Europe, Factual, Female, HIV Infections, HIV-1, HIV-1-INFECTED PATIENTS, Humans, Male, Middle aged, NAIVE, Oligopeptides, ONCE-DAILY ATAZANAVIR, PROTEASE INHIBITORS, Pyridines, Retrospective Studies, RITONAVIR, RNA

وصف الملف: 564–573

Relation: urn:issn:0889-2229; urn:issn:1931-8405

الاتاحة: https://bibliographie.ub.rub.de/entry/ef239331-f86c-4d8f-8c37-d3d61c4e2e38